Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Invention Grant

US10260084B2 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition 有权

Please log in to see more content

Patent Title: Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
Application No.: US15594162

Application Date: 2017-05-12
Publication No.: US10260084B2

Publication Date: 2019-04-16
Inventor: Brett E. Crawford , Jillian R. Brown , Charles A. Glass , Jim R. Beitel , Robin M. Jackman
Applicant: BIOMARIN PHARMACEUTICAL INC.
Applicant Address: US CA Novato
Assignee: BIOMARIN PHARMACEUTICAL INC.
Current Assignee: BIOMARIN PHARMACEUTICAL INC.
Current Assignee Address: US CA Novato
Agency: Jones Day
Main IPC: G01N33/68
IPC: G01N33/68 ; C12Q1/527 ; C12Q1/40 ; C12Q1/34

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Abstract:

Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.

Public/Granted literature

US20170321246A1 QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION Public/Granted day:2017-11-09

Information query

Espacenet

IPC分类:

G	物理
G01	测量；测试
G01N	借助于测定材料的化学或物理性质来测试或分析材料（除免疫测定法以外包括酶或微生物的测量或试验入C12M，C12Q）
G01N33/00	利用不包括在G01N1/00至G01N31/00组中的特殊方法来研究或分析材料
G01N33/48	.生物物质，例如血、尿（G01N33/02，G01N33/26，G01N33/44，G01N33/46优先）；血球计数器（靠对一表面扫描来统计该表面上的血球数入G06M11/02）
G01N33/50	..••生物物质（例如血、尿）的化学分析；包括了生物特有的配体结合方法的测试；免疫学试验（除了免疫学试验以外包括酶或微生物，以及相应的组分或试纸的检测或试验，形成这些组分的工艺过程，在微生物的或酶的反应过程中反应条件的控制入C12Q）
G01N33/68	...涉及蛋白质、肽或氨基酸的